Multimodality Imaging for the Workup of Coronary Artery Disease

Tuesday, June 7 | 2:30 PM - 4:00 PM
Ballroom C2

Objectives
Upon completion of this activity, the participant will be able to:
1. Discuss the value of multimodality imaging in coronary artery disease.
2. Define the costs associated with potentially improved diagnostic accuracy with multimodality imaging.
3. Review clinically relevant information beyond perfusion that can be obtained by imaging.

Speakers are:
Mark I. Travin, MD, Montefiore Medical Center, Bronx, N.Y.;
Daniel S. Berman, MD, Cedars-Sinai Medical Center in Los Angeles;
Ahmed A. Tawakol, MD, Massachusetts General Hospital; and
Louise Thomson, MBChB, Cedars-Sinai Medical Center in Los Angeles.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.